AAAAAA

   
Results: 1-8 |
Results: 8
Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants
Authors: Kostense, S Krop, E Blaak, H Schuitemaker, H Miedema, F
Citation: S. Kostense et al., Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants, AIDS, 14(3), 2000, pp. 330-331
Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production
Authors: Blaak, H Ran, LJ Rientsma, R Schuitemaker, H
Citation: H. Blaak et al., Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production, VIROLOGY, 267(2), 2000, pp. 237-246
In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline
Authors: Blaak, H van't Wout, AB Brouwer, M Hooibrink, B Hovenkamp, E Schuitemaker, H
Citation: H. Blaak et al., In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline, P NAS US, 97(3), 2000, pp. 1269-1274
Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1
Authors: van Rij, RP Blaak, H Visser, JA Brouwer, M Rientsma, R Broersen, S Husman, AMD Schuitemaker, H
Citation: Rp. Van Rij et al., Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1, J CLIN INV, 106(8), 2000, pp. 1039-1052
Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000)
Authors: van Rij, RP Blaak, H Visser, JA Brouwer, M Rientsma, R Broersen, S Husman, AMD Schuitemaker, H
Citation: Rp. Van Rij et al., Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000), J CLIN INV, 106(12), 2000, pp. 1569-1569
Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
Authors: Prins, JM Jurriaans, S van Praag, RME Blaak, H van Rij, R Schellekens, PTA ten Berge, IJM Yong, SL Fox, CH Roos, MTL de Wolf, F Goudsmit, J Schuitemaker, H Lange, JMA
Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410
Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression
Authors: Husman, AMD van Rij, RP Blaak, H Broersen, S Schuitemaker, H
Citation: Amd. Husman et al., Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression, J INFEC DIS, 180(4), 1999, pp. 1106-1115
CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection
Authors: Husman, AD Blaak, H Brouwer, M Schuitemaker, H
Citation: Ad. Husman et al., CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection, J IMMUNOL, 163(8), 1999, pp. 4597-4603
Risultati: 1-8 |